Glyburide — Discount Pricing
Glyburide is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Glyburide Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $25.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Glyburide
Glyburide is a prescription medication. Ask your doctor if Glyburide is right for you.
How to Check Glyburide Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Glyburide at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Diabetes & Metabolism
About Glyburide
Glyburide is a commonly prescribed medication for managing type 2 diabetes, helping millions control their blood sugar. Understanding its role and how to access it affordably is crucial. TheDrugClub is dedicated to making essential prescriptions like glyburide more accessible and budget-friendly for our members, ensuring you can focus on your health without financial strain.
What is Glyburide and What Does It Treat?
Glyburide is an oral medication primarily used to treat type 2 diabetes mellitus in adults. Type 2 diabetes is a chronic condition where the body either doesn't produce enough insulin or doesn't use insulin effectively, leading to high blood sugar levels. Uncontrolled high blood sugar can
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Glyburide is approved for (FDA label)
Glyburide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Source: Read the full FDA label on DailyMed. Label effective date: June 12, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Glyburide (FDA label)
Hypoglycemia: See Precautions and Overdosage sections. Gastrointestinal Reactions: Cholestatic jaundice and hepatitis may occur rarely which may progress to liver failure; glyburide tablets should be discontinued if this occurs. Liver function abnormalities, including isolated transaminase elevations, have been reported. Gastrointestinal disturbances, eg , nausea, epigastric fullness, and heartburn are the most common reactions, having occurred in 1.8% of treated patients during clinical trials. They tend to be dose related and may disappear when dosage is reduced. Dermatologic Reactions: Allergic skin reactions, eg , pruritus, erythema, urticaria, and morbilliform or maculopapular eruptions occurred in 1.5% of treated patients during clinical trials.
Source: FDA prescribing information (DailyMed). Set ID: 524eec41-37ee-419a-b7a1-d23e888ae6ab. SPL document ID: 54112e49-0ae5-6ec9-e063-6394a90a3616. Label effective date: June 12, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Glyburide (FDA label)
Glyburide tablets are contraindicated in patients with: 1. Known hypersensitivity or allergy to the drug. 2. Diabetic ketoacidosis, with or without coma. This condition should be treated with insulin. 3. Type I diabetes mellitus. 4. Concomitant administration of bosentan.
Source: FDA prescribing information (DailyMed). Set ID: 524eec41-37ee-419a-b7a1-d23e888ae6ab. SPL document ID: 54112e49-0ae5-6ec9-e063-6394a90a3616. Label effective date: June 12, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Glyburide (FDA label)
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including non-steroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents. When such drugs are administered to a patient receiving glyburide tablets the patient should be observed closely for hypoglycemia. When such drugs are withdrawn from a patient receiving glyburide tablets the patient should be observed closely for loss of control. An increased risk of liver enzyme elevations was observed in patients receiving glyburide concomitantly with bosentan. Therefore concomitant administration of glyburide tablets and bosentan is contraindicated. Certain drugs tend to produce hyperglycemia and may lead to loss of control. These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.
Source: FDA prescribing information (DailyMed). Set ID: 524eec41-37ee-419a-b7a1-d23e888ae6ab. SPL document ID: 54112e49-0ae5-6ec9-e063-6394a90a3616. Label effective date: June 12, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.